Deals & Dollars
   Thursday, May 08, 2008 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Why choose Quintiles in Latin America?

In Latin America we provide fully integrated services for Phase I-IV studies including central laboratory services and report writing for US and European (FDA, EMEA, and ICH-GCP) regulatory submissions. Access to patients is rapid, and is concentrated in general tertiary hospitals and a few specialty hospitals with which Quintiles has long-standing relationships.

All of this makes Latin America a logical first choice for clinical trials. And we are the ones who make it work for you.

For more information, please visit:
http://www.quintilesimages.com/southamerica/
HeadHtml
•  Biovail Corporation (BVF) Announces New Strategic Focus; Close Plants and Take Charges More...

More Job Industry News
HeadHtml
•   Jazz Pharmaceuticals, Inc. (JAZZ) Secures $75 Million Committed Equity Financing Facility More...

More Finance News

Latest Market Insight

Drug Approval Trends at the FDA and EMEA

Process improvements, heightened scrutiny and industry response

• Delayed approvals. Regulators are requesting more data to validate or refute conclusions about product risks. This is creating a rise in the size and number of clinical trials as well as overall research budgets.

• Rising R&D costs. Drug developers are continually increasing their R&D expenditures to generate approvable drug applications, despite rising financial pressures in the industry. Emerging technologies such as stem cells, genomics and proteomics are among the most prevalent initiatives being used to identify appropriate drug candidates.

• US generics focus. The FDA is allocating resources to generic drug approvals in an attempt to speed these products to market. However, although Europe has recently developed a clear regulatory path for generic versions of biologicals, this is yet be achieved in the US.

• Regulatory process improvements. Regulators are enhancing their drug review processes with new technologies such as electronic drug applications and technology-based standards for drug review.

Click Here for More Information
HeadHtml
•   DOR BioPharma, Inc. (DORB) Acquires Option for Third-Generation Anthrax Vaccine From Harvard University More...
•   AMDL, Inc. (ADL) Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company More...
•   Quintiles Transnational Corp. Signs Agreement to Acquire Eidetics More...

More Mergers and Acquisitions News
HeadHtml
•   Amnis Corporation and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China More...
•   LFB Biotechnologies and GTC Biotherapeutics (GTCB) to Collaborate on rhAAT Program More...
•   Derma Sciences, Inc. (DSCI) Signs With Amerinet, Inc. for MEDIHONEY(TM) Wound & Burn Dressings More...

More Alliances News

•   NUCRYST Pharmaceuticals Corp. (WEDX) Appoints David B. Holtz as Vice President and Chief Financial Officer More...
•   Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics, Inc. More...
•   Codon Devices Names Kareem Saad to Vice President, Marketing and Business Development More...
•   Kendle International (KNDL) Appoints Patricia Williams Vice President, Commercial Operations Industry Veteran to Lead Global Contract Execution and Negotiation Efforts More...
•   Robert P. Hill Joins Biothera Board of Directors More...

More Personnel News

What Are You Worth?
HeadHtml
•   APP Pharmaceuticals Reports 2008 First Quarter Net Revenues of $148 Million, Gross Profit of $70 Million More...
•   Avalon Pharmaceuticals (AVRX) Reports First Quarter 2008 Results More...
•   Arena Pharmaceuticals, Inc. (ARNA) Announces First Quarter 2008 Financial Results More...
•   AmerisourceBergen (ABC) Approves Quarterly Dividend More...
•   AVI BioPharma, Inc. (AVII) Announces First Quarter 2008 Financial Results Conference Call More...

More Earnings Report News
HeadHtml
•   CRI Worldwide Opens Center for the Research of Pain Disorders in Philadelphia More...

More Construction News
 
Real Estate



Property for Sale
101 Mettlers Road
Somerset, New Jersey
U.S.A.

• BUILDINGS: Four interconnected office, research and development buildings
• Versatile lay-out divides for multi-tenant scenarios.
• 49.2 acres of undeveloped surplus land, which can be used to expand the existing facility or other development opportunities.

More Real Estate Listings
Feature

Hot Company



Rho, Inc.
6330 Quadrangle Drive
Suite 500
Chapel Hill, North Carolina 27517 U.S.A.
Phone: 919-408-8000 or (888) RHO-DATA
Fax: 919-408-0999
View Jobs

Repeat business speaks for itself. At Rho, Inc. we value the loyal relationships of our customers, who rely on us to swiftly ready new products for market. Rho is a full-service clinical research organization dedicated to enhancing the quality and speed of their customers’ clinical trials. Rho provides high quality and timely services in the design, development, and execution of all phases of clinical research. Rho has contributed to the success of pharmaceutical and biotech studies in a wide range of therapeutic areas since 1984.

More Company Profiles
Events
DIA Annual Convention:

Join more than 8,000 attendees as they share information about the latest innovations in drug development and search for solutions to industry challenges.

Highlights of this year's event:
• Over 360 sessions across 26 content areas
• 40 preconference tutorials
• Over 1000 speakers, including representatives from FDA, EMEA, and other global regulatory agencies
• 500+ exhibiting companies
• Networking Reception at the Boston Museum of Science

Please click here for more information.

More Investor Events
More Business Development Events
 
Top Jobs
Biotech Bay (San Francisco, California) Hot Job of the Day:

Medivation, Inc.
Director, Oncology Marketing
The Director will be responsible for optimizing commercial development for a novel compound for hormone-refractory prostate cancer currently in Phase II trials. He or she will also serve as the product champion within the Company.

Biotech Beach (Orange County, California) Hot Job of the Day:

Integrium
Director of Business Development - West Coast
The Business Development Director is responsible for securing new business from pharmaceutical, biotech, and device companies within Integrium’s target market in the assigned territory.

Bio NC (Morrisville, North Carolina) Hot Job of the Day:

Schering-Plough Corporation
Director, Commercial Development
Manage the customers and sales process from initial contact through the signing of a contract by using all tools at their disposal including involving senior management, marketing and sales support.

Pharm Country (Upper Gwynedd, Pennsylvania) Hot Job of the Day:

Smith Hanley Consulting Group
Medical Program Financial Specialist II
Support the financial management of IISP by developing and maintaining a direct working relationship with the Global Research Specialists, Company Financial Specialist Administrator, paralegals, finance departments, Company subsidiary offices and external customers.

Genetown (Cambridge, Massachusetts) Hot Job of the Day:

Biogen Idec
Sr Analyst III, Business Analysis
Seeking a Senior Oracle Applications Business Systems Analyst (Sr. Analyst III, Business Analyst) experienced in the Oracle 11i finance modules. A qualified candidate must have specific functional experience in Oracle G/L, A/R, A/P, F/A, and Tax. Practical experience with the one or more of these areas is a plus: Project Accounting, Process Manufacturing, and Cost Accounting.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
Career Fairs
BioSpace.com is pleased to present the Boehringer Ingelheim Career Fair TODAY at The Sheraton Boston Hotel in Boston, Massachusetts from 11:00 a.m. to 4:00 p.m. You must pre-register in order to attend this event.

For this event, Boehringer Ingelheim is ONLY interviewing candidates with the following backgrounds:

• Immunology/Inflammatory Disease Research - Scientists with BS, MS, and/or PhD
• Medicinal Chemistry - Scientists and Principal Scientists with MS or PhD
• Cardiovascular Disease Research - Scientists and Principal Scientists with MS or PhD
• Translational Sciences - Director level with PhD experience in Systems Biology and/or Electronic Biology
• Biologics/Biomolecular Sciences - Scientists and Principal Scientists with BS, MS, or Ph.D. and experience in Antibody/protein engineering
• Animal Resources - Facility Managers with BS and GLP experience
• Clinical Trial Support - Scientists with BS or MS degree in related field

We look forward to seeing you at the Boehringer Ingelheim Career Fair!

Boehringer Ingelheim Career Fair, May 8, 2008
Pharm Country Career Fair, June 5, 2008
DDT - BioSpace 2008 Career Fair, August 6, 2008
DeviceSpace Career Fair, September 8, 2008
BioCapital Career Fair, September 30, 2008
Biotech Bay Career Fair, October 14, 2008

More information about BioSpace's Career Fairs
Subscribe/Unsubscribe

If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the BioSpace Deals & Dollars here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here or by clicking on the "unsubscribe" link at the bottom of this newsletter.
 
Contact Us

Send questions and comments to the BioSpace NewsBeat Team East Coast Office:
    BioSpace, Inc.
    Ramshorn Executive Centre
    2399 Highway 34, Building A-5
    Manasquan, New Jersey 08736-1528 U.S.A.
    Phone: 732-528-3688
    Fax: 732-528-3668
West Coast Office:
    BioSpace, Inc.
    90 New Montgomery Street, Suite 414
    San Francisco, California 94105 U.S.A.
    Phone: 877-277-7585
    Fax: 415-576-9217
Editor & Publisher:
    Rosemary Do
Editorial & Production Staff:
    Annalyn Aquino
    Suvarna Bhatt
    Lana Ho
BioSpace.com - Where Life Sciences Thrive.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2008 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.